These results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 help the concept of focusing on ACKR3 as a novel approach to modulate the opioid method, which could open new therapeutic avenues for opioid-connected Diseases. The website is protected. The https://paulg516fwm1.wikimidpoint.com/user